Natera, Inc.

    NTRA ·NASDAQ ·Services-Medical Laboratories ·Inc. in DE
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Recent insider activity

    Last 90 days. Open-market trades (purchases & sales) by directors, officers, and 10%+ owners. 8 transactions across 6 insiders. Net: -20,176 shares, -$4,062,781.

    Date Insider Role Action Shares Price Value
    2026-04-29 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sell -3,070 ×5 $193.74 -$594,789
    2026-04-27 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sell -1,993 ×2 $204.14 -$406,856
    2026-04-29 Sheena Jonathan Director Sell -3,071 ×2 $196.42 -$603,198
    2026-04-27 Sheena Jonathan Director Sell -473 ×2 $204.00 -$96,494
    2026-04-27 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sell -1,861 ×2 $204.09 -$379,811
    2026-04-27 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sell -2,182 ×2 $204.10 -$445,341
    2026-04-27 Fesko John PRESIDENT, CHIEF BUS. OFFICER Sell -1,688 ×2 $204.10 -$344,517
    2026-04-27 Chapman Steven Leonard CEO AND PRESIDENT Sell -5,838 ×2 $204.14 -$1,191,775

    Source: SEC Form 4 filings.

    Next expected filings

    • ~2026-05-09 10-Q expected by 2026-05-10 (in 8 days)
    • ~2026-08-08 10-Q expected by 2026-08-09 (in 99 days)
    • ~2026-11-07 10-Q expected by 2026-11-08 (in 190 days)
    • ~2027-02-26 10-K expected by 2027-04-03 (in 301 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-04-23 DEF 14A Proxy Statement
    • 2026-04-01 8-K Officer/Director Change; Financial Statements and Exhibits
    • 2026-02-27 10-K Annual Report
    • 2026-02-26 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-01-12 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-12-05 S-3 Registration Statement
    • 2025-12-05 8-K Unregistered Equity Sale; Other Events; Financial Statements and Exhibits
    • 2025-11-07 10-Q Quarterly Report
    • 2025-11-06 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-08-08 10-Q Quarterly Report
    • 2025-08-07 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-06-18 8-K Officer/Director Change; Shareholder Vote Results; Financial Statements and Exhibits
    • 2025-05-09 10-Q Quarterly Report
    • 2025-05-08 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-03-12 8-K Officer/Director Change; Financial Statements and Exhibits